| Study of A4250 in Healthy Volunteers Under Fasting, Fed and Sprinkled Conditions (NCT03608319) | Albireo | 2018-07-05 |
| APG-1387 Study of Safety, Tolerability ,PK/PD in Patients With Chronic Hepatitis B (NCT03585322) | Ascentage Pharma Group Inc. | 2018-07-04 |
| Safety and Tolerability of CDX-6114 in Healthy Volunteers (NCT03577886) | Codexis Inc. | 2018-07-04 |
| A Study of RO7172508 in Patients With Locally Advanced and/or Metastatic CEA-Positive Solid Tumors (NCT03539484) | Hoffmann-La Roche | 2018-07-04 |
| FX-322 in Sensorineural Hearing Loss (NCT03616223) | Frequency Therapeutics | 2018-07-03 |
| St. PETERsburg Pain and Alcohol Intervention With Naltrexone and Nalmefene (NCT03278886) | Boston Medical Center | 2018-07-03 |
| A Study to Determine the Effects of PF-04965842 on Midazolam PK in Healthy Volunteers (NCT03647670) | Pfizer | 2018-07-03 |
| Clinical Trial to Evaluate the Safety and Effects of Ethnicity and Food on Pharmacokinetics of YH25448 (NCT03556436) | Yuhan Corporation | 2018-07-03 |
| Safety and Immunogenicity of MT-5625 in Healthy Adults, Toddlers and Infants (NCT03507738) | Tanabe Pharma Corporation | 2018-07-03 |
| Safety, Tolerability, Pharmacokinetics and Food Effects Study of PBTZ169 (NCT04150224) | Nearmedic Plus LLC | 2018-07-03 |
| Effects of Olive Oil and Bran Oil on Antioxidant Levels, Glycemic Control, and Lipid Profile in Patient Type 2 DM (NCT03544411) | Indonesia University | 2018-07-02 |
| E6201 Plus Dabrafenib for the Treatment of Metastatic Melanoma Central Nervous System Metastases (CNS) (NCT03332589) | Spirita Oncology, LLC | 2018-07-02 |
| Safety and Tolerability of Hair Stimulating Complex (HSC) in Female Pattern Hair Loss (NCT03662854) | Histogen | 2018-07-02 |
| A Phase I/II Study of OBI-3424 in Subjects with Advanced Solid Tumors (NCT03592264) | OBI Pharma, Inc | 2018-07-02 |
| A Double-blind, Randomized, Intra-subject Placebo-controlled, Multicenter, Multiple Dose Study, Evaluating Safety, Proof of Mechanism, Preliminary Efficacy and Systemic Exposure in Subjects With Confirmed DDEB or RDEB Diagnosis With One or More Pathogenic Mutations in Exon 73 in the COL7A1 Gene (NCT03605069) | Phoenicis Therapeutics | 2018-07-02 |
| A Study To Determine The Effect Of Single-dose PF-04965842 On QTc Interval In Healthy Volunteers Compared With Placebo and Moxifloxacin (NCT03386279) | Pfizer | 2018-07-02 |
| A Study of ASP1948, Targeting an Immune Modulatory Receptor as a Single Agent and in Combination With a PD-l Inhibitor (Nivolumab or Pembrolizumab) in Subjects With Advanced Solid Tumors (NCT03565445) | Astellas Pharma Global Development, Inc. | 2018-07-02 |
| Single Dose Escalations Study of Amphotericin B Colloidal Dispersion In Healthy Subjects in China (NCT03577509) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2018-07-02 |
| Evaluating the Pharmacokinetics, Safety, and Tolerability of Doravirine (MK-1439) and Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (MK-1439A) in HIV-1-Infected Children and Adolescents (NCT03332095) | National Institute of Allergy and Infectious Diseases (NIAID) | 2018-07-02 |
| Ustekinumab (Anti-IL-12/23p40 Monoclonal Antibody) in Patients With Leukocyte Adhesion Deficiency Type 1 (LAD1) Who Have Inflammatory Pathology (NCT03366142) | National Institute of Allergy and Infectious Diseases (NIAID) | 2018-07-02 |
| INCB050465 in Combination With Rituximab, Bendamustine and Rituximab, or Ibrutinib in Participants With Previously Treated B-Cell Lymphoma (CITADEL-112) (NCT03424122) | Incyte Corporation | 2018-07-02 |
| Study of Nivolumab in Combination With GM.CD40L Vaccine in Adenocarcinoma of the Lung (NCT02466568) | H. Lee Moffitt Cancer Center and Research Institute | 2018-07-01 |
| Clinical Study to Evaluate the Safety and Feasibility of spCART-269 Injection in the Treatment of MM (NCT04500431) | Shanghai Tongji Hospital, Tongji University School of Medicine | 2018-07-01 |
| NK Cells Infusion for Advanced Malignancies (NCT03619954) | Anhui Provincial Hospital | 2018-07-01 |
| A Phase Ib Study of NVX-508 in Sickle Cell Disease (NCT03013426) | Amma Owusu-Ansah, MD | 2018-07-01 |
| The Nitrite and Coronary Flow Study (NCT04354051) | University of East Anglia | 2018-07-01 |
| Efficacy Evaluation of Sequential Treatment With AG and Modified Folfirinox in Metastatic Pancreatic Adenocarcinoma (NCT03633734) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2018-07-01 |
| Safety and Efficacy Evaluation of MUC-1 CART in the Treatment of Intrahepatic Cholangiocarcinoma (NCT03633773) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2018-07-01 |
| Single-dose Potassium Supplementation in Patients With ADHD for Whom the Anesthetic Lidocaine is Ineffective (NCT03563573) | AlkaliDx, Inc. | 2018-07-01 |
| Evaluation of the Efficacy of Prophylactic Topical Gentamicin in Tunnelled Catheters for Hemodialysis (NCT04967859) | Universidade Estadual Paulista Júlio de Mesquita Filho | 2018-07-01 |
| mFLOT Chemotherapy as First-line Treatment in GC (NCT03606928) | Ruijin Hospital | 2018-07-01 |
| REALIB-LLA-2017: Idelalisib in Patients With Acute Lymphoblastic Leukemia (NCT03742323) | PETHEMA Foundation | 2018-07-01 |
| Lutetium-177-PSMA-617 in Low Volume Metastatic Prostate Cancer (NCT03828838) | Radboud University Medical Center | 2018-07-01 |
| Adipose Mesenchymal Stem Cells (AMSC) for Treatment of Ulcerative Colitis (NCT03609905) | Liaocheng People's Hospital | 2018-07-01 |
| Myeloperoxidase (MPO) Inhibitor A_Zeneca for Heart Failure With Preserved Ejection Fraction (HFpEF) (NCT03611153) | Mayo Clinic | 2018-07-01 |
| Follow-Up Study of Mesenchymal Stem Cells for Bronchopulmonary Dysplasia (NCT03873506) | Children's Hospital of Chongqing Medical University | 2018-07-01 |
| Venetoclax, Lenalidomide and Rituximab in Patients With Relapsed/Refractory Mantle Cell Lymphoma (NCT03505944) | Nordic Lymphoma Group | 2018-07-01 |
| DEBOXA for Inoperable NET Liver Metastases (NCT03881306) | Xiangya Hospital of Central South University | 2018-07-01 |
| Efficacy Evaluation of Propranolol Treatment of Hepatic Hemangioma (NCT03633747) | Second Affiliated Hospital, Zhejiang University, School of Medicine | 2018-07-01 |
| Orthostatic Intolerance After Bariatric Surgery (NCT03808740) | Vanderbilt University Medical Center | 2018-07-01 |
| A PhaseI Study of HL-085 Plus Vemurafenib in Solid Tumor With BRAF V600 Mutation (NCT03781219) | Shanghai Kechow Pharma, Inc. | 2018-07-01 |
| Nab-Sirolimus in Combination With FOLFOX & BEV as 1st Line Therapy in Patients With Advanced or Metastatic Colorectal Cancer (NCT03439462) | Aadi Bioscience, Inc. | 2018-07-01 |
| A Study to Evaluate the Safety and Immunogeneicity of Multivalent Pneumococcal Conjugate Vaccine in Healthy Adults (NCT03549208) | LG Chem | 2018-07-01 |
| Moderate Whole Body Hyperthermia for Patients Undergoing Re-irradiation for Head and Neck Cancer -Influence on the Tumor Microenvironment (NCT03547388) | Charite University, Berlin, Germany | 2018-07-01 |
| A Preliminary Clinical Study on the Pharmacokinetics and Safety of CDP1 in Patients With Advanced CRC or HNSCC (NCT03491709) | Dragonboat Biopharmaceutical Company Limited | 2018-07-01 |
| Vaginal Microbiome Seeding and Health Outcomes in Cesarean-delivered Neonates. (NCT03298334) | National Institute of Allergy and Infectious Diseases (NIAID) | 2018-07-01 |
| Dasatinib Combined With Chemotherapy in Relapsed t(8;21) Acute Myeloid Leukemia With KIT D816 Mutation (NCT03560908) | Institute of Hematology & Blood Diseases Hospital, China | 2018-07-01 |
| Intracavernous Injection of Autologous Mesenchymal Stem Cells in the Treatment of Erectile Dysfunction Resistant to Oral Treatment in Patients With Type I Diabetes (NCT03361631) | Central Hospital, Nancy, France | 2018-06-30 |
| A Bioequivalence Study of Glibenclamide From Glibesyn 5 mg Tablets (Medochemie LTD Cyprus) and Daonil 5 mg Tablets (Sanofi-Aventis Cyprus Ltd. ) (NCT03855306) | Genuine Research Center, Egypt | 2018-06-30 |
| The Efficacy of a Herbal Supplement in the Prevention of PTSD (NCT03724448) | Hôpital Universitaire Sahloul | 2018-06-30 |
| Evaluating the Infectivity, Safety and Immunogenicity of Respiratory Syncytial Virus Vaccines, RSV 6120/∆NS1 and RSV 6120/F1/G2/∆NS1, in RSV-Seropositive Children and RSV-Seronegative Infants and Children (NCT03596801) | National Institute of Allergy and Infectious Diseases (NIAID) | 2018-06-29 |
| Window of Opportunity Trial of Neoadjuvant Olaparib and Durvalumab for Triple Negative or Low ER+ Breast Cancer (NCT03594396) | Seoul National University Hospital | 2018-06-29 |
| A Study of JNJ-68284528, a Chimeric Antigen Receptor T Cell (CAR-T) Therapy Directed Against B-Cell Maturation Antigen (BCMA) in Participants With Relapsed or Refractory Multiple Myeloma (NCT03548207) | Janssen Research & Development, LLC | 2018-06-29 |
| PEP-CMV in Recurrent MEdulloblastoma/Malignant Glioma (NCT03299309) | Daniel Landi | 2018-06-29 |
| A Study of JNJ-64565111 After Single Subcutaneous Administration at Different Injection Sites in Otherwise Healthy Overweight/Obese Adult Participants and a Study of JNJ-6456511 in Otherwise Healthy Obese Adult Participants After Multiple Dose (NCT03586843) | Janssen Research & Development, LLC | 2018-06-29 |
| Probiotics and Gut Health (NCT03418857) | Penn State University | 2018-06-29 |
| Nicotinic Hepatic Metabolism on Neuroreceptor Substrates of Nicotine Addiction (NCT03442413) | University of Pennsylvania | 2018-06-28 |
| Microwave Ablation With MRI-Guided SBRT Boost in Renal Cell Carcinoma (NCT02782715) | University of Wisconsin, Madison | 2018-06-28 |
| Human Mesenchymal Stem Cells For Bronchopulmonary Dysplasia (NCT03558334) | Children's Hospital of Chongqing Medical University | 2018-06-28 |
| BAY1830839: First in Man, Single Dose Escalation, Safety & Tolerability and Pharmacokinetics (NCT03540615) | Bayer | 2018-06-28 |
| A Study of Injection HB002.1T in Subjects With Solid Tumor (NCT03636750) | Huabo Biopharm Co., Ltd. | 2018-06-28 |
| A Study of Cetrelimab (JNJ-63723283), a Programmed Cell Death Receptor-1 (PD-1) Inhibitor, Administered in Combination With Apalutamide in Participants With Metastatic Castration-Resistant Prostate Cancer (NCT03551782) | Janssen Research & Development, LLC | 2018-06-28 |
| A Study to Compare PK, PD and Safety of CKD-381 and D026 in Healthy Subjects (NCT03558425) | Chong Kun Dang Pharmaceutical | 2018-06-27 |
| IBI308 in Subjects With Advanced/Metastatic Solid Malignancies (NCT03568539) | Innovent Biologics (Suzhou) Co. Ltd. | 2018-06-27 |
| CAB-ROR2-ADC Safety and Efficacy Study in Patients With TNBC or Head & Neck Cancer (Ph1) and NSCLC or Melanoma (Ph2) (NCT03504488) | BioAtla, Inc. | 2018-06-27 |
| Study of Trametinib + Ceritinib in Patients With Unresectable Melanoma (NCT03501368) | H. Lee Moffitt Cancer Center and Research Institute | 2018-06-27 |
| Study of REGN4659 in Combination With Cemiplimab in Patients With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) (NCT03580694) | Regeneron Pharmaceuticals | 2018-06-27 |
| A Study of INCB059872 in Relapsed or Refractory Ewing Sarcoma (NCT03514407) | Incyte Corporation | 2018-06-27 |
| Study in Healthy Volunteers Evaluating Safety and Pharmacokinetics of Zika Virus Immune Globulin (ZIKV-IG) (NCT03624946) | Emergent BioSolutions | 2018-06-27 |
| Inhaled Anesthetics and Myocardial Strain (NCT03569085) | Kathirvel Subramaniam | 2018-06-27 |
| A Study of Lasmiditan in Healthy Japanese and Caucasian Participants (NCT03579940) | Eli Lilly and Company | 2018-06-27 |
| Venetoclax, Ponatinib, and Dexamethasone in Participants With Philadelphia Chromosome or BCR-ABL Positive Relapsed or Refractory Acute Lymphoblastic Leukemia or Chronic Myelogenous Leukemia (NCT03576547) | M.D. Anderson Cancer Center | 2018-06-26 |
| Phase 1 Study to Assess AER-271 (NCT03804476) | Aeromics, Inc. | 2018-06-26 |
| TITAN (Tumoural Injection of T-VEC and Isolated Limb Perfusion) (NCT03555032) | Royal Marsden NHS Foundation Trust | 2018-06-26 |
| Pembrolizumab and Trametinib in Treating Patients With Stage IV Non-Small Cell Lung Cancer and KRAS Gene Mutations (NCT03299088) | Jonathan Riess | 2018-06-26 |
| A Study to Investigate a New Treatment in Patients With Parkinson's Disease (NCT03407378) | Tools4Patient | 2018-06-26 |
| First-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma (NCT03625037) | Genmab | 2018-06-26 |
| A Drug-drug Interaction (DDI) Study of Morphothiadine Mesilate/Ritonavir in Healthy Subjects (NCT03662568) | Sunshine Lake Pharma Co., Ltd. | 2018-06-26 |
| Study of Multiple Doses of PRS-060 Administered by Oral Inhalation in Subjects With Mild Asthma (NCT03574805) | Pieris Australia Pty Ltd | 2018-06-26 |
| Biweekly SOLAR, as First-line C/T in Pts With Gastric, Pancreatic and Biliary Cancers (NCT03162510) | National Health Research Institutes, Taiwan | 2018-06-26 |
| A Study to Evaluate the Long-term Safety and Tolerability of Lu AF20513 and the Antibody Response in Patients With Alzheimer's Disease (AD) (NCT03668405) | H. Lundbeck A/S | 2018-06-26 |
| A Study to Compare Levels of Capsaicin After Intra-Articular Injection and Topical Application in Patients With Painful Knee Osteoarthritis (NCT03576508) | Centrexion Therapeutics | 2018-06-25 |
| ARQ761 + PARP Inhibitor in Refractory Solid Tumors (NCT03575078) | University of Texas Southwestern Medical Center | 2018-06-25 |
| 4-Week, Multiple-dose, Dose-escalating Study In Patients With Type 2 Diabetes (NCT03538743) | Pfizer | 2018-06-25 |
| Effects of GSK2798745 on Alveolar Barrier Disruption in a Segmental Lipopolysaccharide (LPS) Challenge Model (NCT03511105) | GlaxoSmithKline | 2018-06-25 |
| A Single Arm, Open-label,Phase Ib Study of CT053PTSA in Preciously Treated Patients With Advanced and Metastatic RCC (NCT03876925) | Sunshine Lake Pharma Co., Ltd. | 2018-06-25 |
| A Study Assessing the Safety and Pharmacokinetic Profile of Modified Release Formulations of Tolcapone (NCT03633591) | Corino Therapeutics, Inc. | 2018-06-25 |
| A Phase 1 Study of AMV564 in Patients With Intermediate or High-Risk Myelodysplastic Syndromes (NCT03516591) | Amphivena Therapeutics, Inc. | 2018-06-22 |
| A Study to Evaluate the Safety and Tolerability of Tecarfarin in Healthy Chinese Volunteers (NCT03652779) | Lee's Pharmaceutical Limited | 2018-06-22 |
| Bioavailability Study of COQUN ORAL FORMULATION (NCT03819491) | VISUfarma SpA | 2018-06-22 |
| MEDI9447(Oleclumab) Pancreatic Chemotherapy Combination Study. (NCT03611556) | MedImmune LLC | 2018-06-21 |
| This is a Trial of MG1-E6E7 With Ad-E6E7 and Atezolizumab in Patients With HPV Associated Cancers (NCT03618953) | Turnstone Biologics, Corp. | 2018-06-21 |
| 2-Week Study In People With Nonalcoholic Fatty Liver Disease (NCT03513588) | Pfizer | 2018-06-21 |
| A Study of Gemcitabine, Nab-paclitaxel, Capecitabine, Cisplatin, and Irinotecan in Metastatic Pancreatic Cancer (NCT03535727) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2018-06-21 |
| Phase I, Open-Label, Dose-Escalation Study of a Human Monoclonal Antibody, VRC-HIVMAB091-00-AB (N6LS), Administered Intravenously or Subcutaneously With or Without Recombinant Human Hyaluronidase PH20 (rHuPH20) (NCT03538626) | National Institute of Allergy and Infectious Diseases (NIAID) | 2018-06-21 |
| Cabometyx and Avelumab in Patients With Metastatic Renal Cell Carcinoma (mRCC) (NCT03200587) | University of Utah | 2018-06-21 |
| A Pilot Trial of Triheptanoin for People With Amyotrophic Lateral Sclerosis (PALS) (NCT03506425) | Richard Bedlack, M.D., Ph.D. | 2018-06-21 |
| A Combined SAD and MAD Study to Investigate the Safety, Tolerability and Pharmacokinetic Profile of IFB-088 (NCT03610334) | InFlectis BioScience | 2018-06-21 |
| A Study of TQ-B3525 on Tolerance and Pharmacokinetics (NCT03510767) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2018-06-20 |
| Antiviral Cellular Therapy for Enhancing T-cell Reconstitution Before or After Hematopoietic Stem Cell Transplantation (NCT03475212) | Pediatric Transplantation & Cellular Therapy Consortium | 2018-06-20 |